The CDC’s Advisory Committee on Immunization Practices voted unanimously, 13-0, today to recommend that the current Japanese encephalitis vaccine recommendations be extended to include children aged 2 months to 16 years, according to a presentation during the meeting.
In 2009, the Japanese encephalitis vaccine (Ixiaro, Valneva) was approved for use in travelers aged at least 17 years planning to spend a month or longer in endemic areas during the Japanese encephalitis virus season.
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.